X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs GLENMARK PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS GLENMARK PHARMA J.B.CHEMICALS/
GLENMARK PHARMA
 
P/E (TTM) x 17.0 13.5 125.8% View Chart
P/BV x 2.1 2.4 88.7% View Chart
Dividend Yield % 0.5 0.4 126.2%  

Financials

 J.B.CHEMICALS   GLENMARK PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
GLENMARK PHARMA
Mar-18
J.B.CHEMICALS/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs363930 39.0%   
Low Rs255517 49.3%   
Sales per share (Unadj.) Rs169.1322.6 52.4%  
Earnings per share (Unadj.) Rs16.628.5 58.3%  
Cash flow per share (Unadj.) Rs23.439.2 59.8%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.60.3 234.2%  
Book value per share (Unadj.) Rs172.5183.0 94.3%  
Shares outstanding (eoy) m83.57282.17 29.6%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.2 81.5%   
Avg P/E ratio x18.625.4 73.3%  
P/CF ratio (eoy) x13.218.5 71.5%  
Price / Book Value ratio x1.84.0 45.3%  
Dividend payout %12.07.0 171.6%   
Avg Mkt Cap Rs m25,827204,206 12.6%   
No. of employees `0003.813.7 27.5%   
Total wages/salary Rs m2,51118,718 13.4%   
Avg. sales/employee Rs Th3,747.46,636.8 56.5%   
Avg. wages/employee Rs Th665.71,364.7 48.8%   
Avg. net profit/employee Rs Th367.8586.1 62.7%   
INCOME DATA
Net Sales Rs m14,13591,031 15.5%  
Other income Rs m366914 40.0%   
Total revenues Rs m14,50191,945 15.8%   
Gross profit Rs m2,17816,154 13.5%  
Depreciation Rs m5703,019 18.9%   
Interest Rs m352,856 1.2%   
Profit before tax Rs m1,94011,193 17.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5523,155 17.5%   
Profit after tax Rs m1,3878,039 17.3%  
Gross profit margin %15.417.7 86.8%  
Effective tax rate %28.528.2 101.0%   
Net profit margin %9.88.8 111.1%  
BALANCE SHEET DATA
Current assets Rs m10,47069,887 15.0%   
Current liabilities Rs m2,74932,879 8.4%   
Net working cap to sales %54.640.7 134.4%  
Current ratio x3.82.1 179.2%  
Inventory Days Days5581 67.8%  
Debtors Days Days7893 83.1%  
Net fixed assets Rs m5,81128,892 20.1%   
Share capital Rs m167282 59.2%   
"Free" reserves Rs m14,24851,353 27.7%   
Net worth Rs m14,41651,635 27.9%   
Long term debt Rs m041,418 0.0%   
Total assets Rs m17,649125,954 14.0%  
Interest coverage x56.64.9 1,149.9%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x0.80.7 110.8%   
Return on assets %8.18.6 93.2%  
Return on equity %9.615.6 61.8%  
Return on capital %13.715.1 90.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16436,317 17.0%   
Fx outflow Rs m1,3349,720 13.7%   
Net fx Rs m4,82926,598 18.2%   
CASH FLOW
From Operations Rs m1,23116,481 7.5%  
From Investments Rs m-208-10,133 2.1%  
From Financial Activity Rs m-595-4,685 12.7%  
Net Cashflow Rs m4271,770 24.1%  

Share Holding

Indian Promoters % 55.4 48.3 114.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 6.9 49.1%  
FIIs % 3.9 34.4 11.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 56,727 53.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 71 Points Lower; Metal and Energy Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their volatile trading day marginally lower.

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

GLENMARK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 11.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, GLENMARK PHARMA has posted a net profit of Rs 1 bn (up 11.1% YoY). Sales on the other hand came in at Rs 26 bn (up 15.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

7 Bluechips to Profit from Tech Disruption(Profit Hunter)

Jun 17, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 24, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - SUN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS